Blood Research

Cited by CrossRef (12)

  1. Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Cheolwon Suh. Single-Center Real-World Experience of Multiple Myeloma in the 21st Century. Korean J Med 2022;97:125
    https://doi.org/10.3904/kjm.2022.97.2.125
  2. Yaeni Kim, Sung-Soo Park, Young-Woo Jeon, Seung-Ah Yahng, Seung-Hwan Shin, Chang-Ki Min. Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 Study. Transplantation and Cellular Therapy 2023;29:55.e1
    https://doi.org/10.1016/j.jtct.2022.09.024
  3. Seung Yeon Kim, Sung-Soo Park, Ji-Young Lim, Jung Yeon Lee, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Hee-Je Kim, Chang-Ki Min. Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone. Experimental Hematology 2022;110:60
    https://doi.org/10.1016/j.exphem.2022.03.012
  4. A.I. Shikhlyarova, N.Е. Zuderman, N.D. Ushakova, E.M. Frantsiyants, I.А. Goroshinskaya, I.V. Kaplieva, I.V. Neskubina, E.A. Sheiko, I.B. Lysenko. Structural oncomarkers in blood plasma in patients with multiple myeloma when using accompanying selective plasma exchange and chemotherapy. CM 2021:22
    https://doi.org/10.18137/cardiometry.2021.20.2128
  5. Sung-Hoon Jung. Recent advances in the treatment of multiple myeloma. J Korean Med Assoc 2023;66:245
    https://doi.org/10.5124/jkma.2023.66.4.245
  6. Jung Yeon Lee, Sung-Soo Park, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Chang-Ki Min. Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study. J Cancer Res Clin Oncol 2023;149:11907
    https://doi.org/10.1007/s00432-023-04993-8
  7. Jeongmin Yim, Sung-Soo Park, Jong-Mi Lee, Jae-Ho Yoon, Hee-Je Kim, Chang-Ki Min. Successful recovery of poor graft function by administration of romiplostim in a multiple myeloma case with poor graft function following autologous stem cell transplantation. Blood Res 2023;58:237
    https://doi.org/10.5045/br.2023.2023185
  8. Harshini Sriram, Florence Kunjachan, Twinkle Khanka, Sangamitra Gawai, Sitaram Ghogale, Nilesh Deshpande, Karishma Girase, Jagruti Patil, Gaurav Chatterjee, Sweta Rajpal, Nikhil V. Patkar, Bhausaheb Bagal, Hasmukh Jain, Manju Sengar, Syed Khizer Hasan, Navin Khattry, Papagudi G. Subramanian, Sumeet Gujral, Prashant R. Tembhare. Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent. Cytometry Part B Clinical 2022;102:462
    https://doi.org/10.1002/cyto.b.22099
  9. Qian Li, Linhui Hu, Alice Charwudzi, Weiwei Zhu, Ye Meng, Zhimin Zhai. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at diagnosis in untreated multiple myeloma patients: a systematic review and meta-analysis. Clin Exp Med 2022
    https://doi.org/10.1007/s10238-021-00775-z
  10. Valentina Urzì Brancati, Letteria Minutoli, Herbert Ryan Marini, Domenico Puzzolo, Alessandro Allegra. Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment. Current Oncology 2023;30:4603
    https://doi.org/10.3390/curroncol30050348
  11. José-Ángel Hernández-Rivas, Mario Arnao, José Maria Arguiñano Pérez, Araceli Rubio, Esther Gónzalez García, Dunia de Miguel, Dasha Cherepanov, Dorothy Romanus, Katharina Verleger, Courtney Johnson, Shelby L Corman, Marta Grande, Ernesto Pérez Persona. Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain. Future Oncology 2021;17:3465
    https://doi.org/10.2217/fon-2021-0301
  12. Xianquan Zhan, Miaolong Lu. Ubiquitin - Proteasome Pathway. 2021.
    https://doi.org/10.5772/intechopen.93586
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd